Mariner, LLC Cytek Biosciences, Inc. Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Mariner, LLC holds 13,098 shares of CTKB stock, worth $52,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,098
Previous 15,317
14.49%
Holding current value
$52,392
Previous $84,000
1.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
72.5MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$68.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$46.9 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$33 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$26.6 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$18 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $539M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...